Daiwa SB Investments Ltd. Raises Holdings in UnitedHealth Group Incorporated (UNH)
Daiwa SB Investments Ltd. grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 51,310 shares of the healthcare conglomerate’s stock after purchasing an additional 1,860 shares during the quarter. UnitedHealth Group comprises about 2.6% of Daiwa SB Investments Ltd.’s holdings, making the stock its 15th biggest holding. Daiwa SB Investments Ltd.’s holdings in UnitedHealth Group were worth $9,514,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. State Street Corp raised its holdings in UnitedHealth Group by 2.5% in the 1st quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after purchasing an additional 1,122,534 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in UnitedHealth Group by 29.9% in the 1st quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock worth $546,574,000 after purchasing an additional 766,573 shares in the last quarter. Swiss National Bank raised its holdings in UnitedHealth Group by 25.8% in the 1st quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock worth $610,033,000 after purchasing an additional 763,161 shares in the last quarter. Karp Capital Management Corp bought a new position in UnitedHealth Group in the 1st quarter worth $113,729,000. Finally, Old Mutual Global Investors UK Ltd. bought a new position in UnitedHealth Group in the 1st quarter worth $109,807,000. Institutional investors and hedge funds own 86.19% of the company’s stock.
UNH has been the subject of several research reports. Vetr lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $179.00 price objective for the company. in a report on Monday, May 22nd. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $193.00 price objective for the company in a report on Monday, May 22nd. Morgan Stanley initiated coverage on shares of UnitedHealth Group in a report on Tuesday, June 6th. They issued an “overweight” rating and a $202.00 price objective for the company. BidaskClub upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, June 9th. Finally, Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, June 9th. One research analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $203.41.
In other news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now owns 60,834 shares in the company, valued at $12,135,774.66. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. Insiders sold 76,174 shares of company stock valued at $14,981,909 over the last quarter. 0.89% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: “Daiwa SB Investments Ltd. Raises Holdings in UnitedHealth Group Incorporated (UNH)” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2017/09/19/daiwa-sb-investments-ltd-raises-holdings-in-unitedhealth-group-incorporated-unh.html.
Shares of UnitedHealth Group Incorporated (UNH) traded down 2.37% during mid-day trading on Tuesday, hitting $193.50. 1,671,187 shares of the stock were exchanged. The stock’s 50 day moving average is $195.48 and its 200-day moving average is $181.07. The stock has a market cap of $187.09 billion, a PE ratio of 23.25 and a beta of 0.63. UnitedHealth Group Incorporated has a 12 month low of $133.03 and a 12 month high of $200.76.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.96 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.51%. UnitedHealth Group’s dividend payout ratio is presently 35.13%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.